XML 68 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2013
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail
Pharmacy
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
June 30, 2013:
 
 
 
 
 
 
 
 
 
Net revenues
$
18,800

 
$
16,139

 
$

 
$
(3,691
)
 
$
31,248

Gross profit
963

 
5,000

 

 
(127
)
 
5,836

Operating profit (loss)
675

 
1,596

 
(176
)
 
(127
)
 
1,968

June 30, 2012:
 

 
 

 
 

 
 

 
 

Net revenues
18,423

 
15,846

 

 
(3,555
)
 
30,714

Gross profit
777

 
4,769

 

 
(97
)
 
5,449

Operating profit (loss)
511

 
1,469

 
(175
)
 
(97
)
 
1,708

Six Months Ended
 

 
 

 
 

 
 

 
 

June 30, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
37,111

 
32,191

 

 
(7,291
)
 
62,011

Gross profit
1,731

 
9,952

 

 
(265
)
 
11,418

Operating profit (loss)
1,174

 
3,133

 
(375
)
 
(265
)
 
3,667

June 30, 2012:
 

 
 

 
 

 
 

 
 

Net revenues
36,722

 
31,869

 

 
(7,079
)
 
61,512

Gross profit
1,393

 
9,341

 

 
(172
)
 
10,562

Operating profit (loss)
860

 
2,766

 
(343
)
 
(172
)
 
3,111

Total assets:
 

 
 

 
 

 
 

 
 

June 30, 2013
36,271

 
29,639

 
1,364

 
(990
)
 
66,284

December 31, 2012
36,057

 
29,183

 
1,408

 
(736
)
 
65,912

Goodwill:
 

 
 

 
 

 
 

 
 

June 30, 2013
19,658

 
6,896

 

 

 
26,554

December 31, 2012
19,646

 
6,749

 

 

 
26,395


(1)          Net revenues of the Pharmacy Services Segment include approximately $2.0 billion and $2.1 billion of retail co-payments for the three months ended June 30, 2013 and 2012, respectively, as well as $4.2 billion and $4.4 billion of retail co-payments for the six months ended June 30, 2013 and 2012, respectively.
(2)        Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity: net revenues of $1.1 billion and $840 million for the three months ended June 30, 2013 and 2012, respectively, and $2.0 billion and $1.6 billion for the six months ended June 30, 2013 and 2012 respectively; gross profit and operating profit of $127 million and $97 million for the three months ended June 30, 2013 and 2012, respectively, and $265 million and $172 million for the six months ended June 30, 2013 and 2012, respectively.